✦ LIBER ✦

Serum soluble ICAM-1 and gelatinase B novel markers of clinical efficacy of the RIFN-beta-1b in relapsing-remitting multiple sclerosis

✍ Scribed by M. Trojano; C. Avolio; M. Ruggieri; M.G. Liuzzi; G. Defazio; M. Santacroce; P. Riccio; P. Livrea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal analyses of the effects of

✍ Petkau, A. John; White, Richard A.; Ebers, George C.; Reder, Anthony T.; Sibley, 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 325 KB

Alemtuzumab versus interferon beta-1a in

✍ Alasdair J Coles; Edward Fox; Anton Vladic; Suzanne K Gazda; Vesna Brinar; Krzys 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 306 KB

Efficacy and safety of subcutaneous inte

✍ Nicola De Stefano; Maria Pia Sormani; Bettina Stubinski; Gregg Blevins; Jelena S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Synergistic immunomodulatory effects of

✍ Frank Weber; Thomas Polak; Astrid Günther; Boris Kubuschok; Julia Janovskaja; An 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

Further study on the specificity and inc

✍ Guido Antonelli; Eleonora Simeoni; Francesca Bagnato; Carlo Pozzilli; Ombretta T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Interferon beta-1b inhibits gelatinase s

✍ David Leppert; Emmanuelle Waubant; Martin R. Bürk; Jorge R. Oksenberg; Stephen L 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB